This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2
Lili Cao, Min Wang, Yujin Dong, Bo Xu, Ju Chen, Yu Ding, Shusheng Qiu, Liang Li, Elena Karamfilova Zaharieva, Xinwen Zhou, Yanbin Xu

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircular RNAs in diseases · GDF15 and Related Biomarkers · Biomarkers in Disease Mechanisms
Retraction Note to: Cell Death & Disease 10.1038/s41419-020-2336-0, published online 24 February 2020
The Editors-in-Chief have retracted this article.
After publication, concerns were raised on images presented in this article for overlaps with itself and another retracted article [1].
Specifically:
In Fig. 2C: Panel sh-NC and circRNF20OE appear to overlap.
In Fig. 2C: Panel Vector and sh-circRNF20 appear to overlap.
Also, Image sh-circRNF20 from Fig. 2C of this article and Image NC from Fig. 2G of the retracted article [1] appear to be similar.
This and the retracted article were submitted within a close timeframe, however there are no common authors. The authors were contacted to clarify the issues but they were unable to provide the complete raw data. The Editors therefore have lost confidence in the data presented in this article.
The authors have not responded to correspondence from the Publisher about this retraction.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. RETRACTED ARTICLE: Circular RNA circ FBXO 11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through mi R-605/FOXO 3/ABCB 1 axis. J Cell Mol Med. 2020;24:5152–61. 10.1111/jcmm.15162.10.1111/jcmm.15162 PMC 720583032222024 · doi ↗ · pubmed ↗
